New trends in PAF antagonist research: a new series of potent hetrapazine-derived PAF antagonists.
Braquet
P
P
Institut Henri Beaufour, Le Plessis-Robinson, France.
Esanu
A
A
D000818:Animals; D001381:Azepines / Q000494:pharmacology / Q000627:therapeutic use; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D013777:Tetrazoles / Q000494:pharmacology / Q000627:therapeutic use; D058924:Thienopyridines; D014230:Triazoles / Q000494:pharmacology / Q000627:therapeutic use
D001381:Azepines; D010972:Platelet Activating Factor; D013777:Tetrazoles; D058924:Thienopyridines; D014230:Triazoles; C061327:BN 50726; C064509:BN 50739; C066686:BN 50730; C067429:Setipafant